USPTO Assignments on the Web

	United States Patent and Trademark Office
	Home\|Site Index\|Search\|Guides\|Contacts\|eBusiness\|eBiz alerts\|News\|Help

Assignments on the Web > Patent Query

Patent Assignment Details

NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:	067348/0160			Pages:	14
		Recorded:	05/08/2024
Attorney Dkt #:	17933.001
Conveyance:	SECURITY INTEREST (SEE DOCUMENT FOR DETAILS).

Total properties: 98

Patent #:	9801942	Issue Dt:	10/31/2017	Application #:	13654770	Filing Dt:	10/18/2012
Publication #:	US20130108633	Pub Dt:	05/02/2013
Title:	Etanercept Formulations Stabilized with Metal Ions

Patent #:	9393305	Issue Dt:	07/19/2016	Application #:	13654919	Filing Dt:	10/18/2012
Publication #:	US20130101584	Pub Dt:	04/25/2013
Title:	Etanercept Formulations Stabilized with Xylitol

Patent #:	9675603	Issue Dt:	06/13/2017	Application #:	13824776	Filing Dt:	06/03/2013
Publication #:	US20130243865	Pub Dt:	09/19/2013
Title:	SOLID PHARMACEUTICAL COMPOSITIONS OF PPARY MODULATOR

Patent #:	9061020	Issue Dt:	06/23/2015	Application #:	14162723	Filing Dt:	01/23/2014
Publication #:	US20140213612	Pub Dt:	07/31/2014
Title:	PPAR GAMMA AGONISTS FOR TREATMENT OF MULTIPLE SCLEROSIS

Patent #:	9765139	Issue Dt:	09/19/2017	Application #:	14226522	Filing Dt:	03/26/2014
Publication #:	US20140296489	Pub Dt:	10/02/2014
Title:	PERFUSION METHOD FOR MANUFACTURING ETANERCEPT

Patent #:	10822429	Issue Dt:	11/03/2020	Application #:	14592569	Filing Dt:	01/08/2015
Publication #:	US20150125532	Pub Dt:	05/07/2015
Title:	Etanercept Formulations Exhibiting Marked Reduction in Sub-Visible Particles

Patent #:	9662396	Issue Dt:	05/30/2017	Application #:	14592654	Filing Dt:	01/08/2015
Publication #:	US20150196645	Pub Dt:	07/16/2015
Title:	STABLE AQUEOUS FORMULATIONS OF ETANERCEPT

Patent #:	10047141	Issue Dt:	08/14/2018	Application #:	14609225	Filing Dt:	01/29/2015
Publication #:	US20150210750	Pub Dt:	07/30/2015
Title:	METHOD OF MANUFACTURING A PROTEIN BY PERFUSION IN MEDIA WITH A LOW AMINO ACID CONCENTRATION

Patent #:	9340611	Issue Dt:	05/17/2016	Application #:	14643844	Filing Dt:	03/10/2015
Publication #:	US20150182626	Pub Dt:	07/02/2015
Title:	Stable Aqueous Formulations of Adalimumab

Patent #:	9340612	Issue Dt:	05/17/2016	Application #:	14661288	Filing Dt:	03/18/2015
Publication #:	US20150190512	Pub Dt:	07/09/2015
Title:	Stable Aqueous Formulations of Adalimumab

Patent #:	9782479	Issue Dt:	10/10/2017	Application #:	14661849	Filing Dt:	03/18/2015
Publication #:	US20150190513	Pub Dt:	07/09/2015
Title:	Stable Aqueous Formulations of Adalimumab

Patent #:	9346880	Issue Dt:	05/24/2016	Application #:	14661899	Filing Dt:	03/18/2015
Publication #:	US20150191538	Pub Dt:	07/09/2015
Title:	Stable Aqueous Formulations of Adalimumab

Patent #:	9382317	Issue Dt:	07/05/2016	Application #:	14661938	Filing Dt:	03/18/2015
Publication #:	US20150191539	Pub Dt:	07/09/2015
Title:	Stable Aqueous Formulations of Adalimumab

Patent #:	9539249	Issue Dt:	01/10/2017	Application #:	14707122	Filing Dt:	05/08/2015
Publication #:	US20150238478	Pub Dt:	08/27/2015
Title:	PPAR GAMMA AGONISTS FOR TREATMENT OF MULTIPLE SCLEROSIS

Patent #:	10975138	Issue Dt:	04/13/2021	Application #:	14788250	Filing Dt:	06/30/2015
Publication #:	US20160122427	Pub Dt:	05/05/2016
Title:	CORRECTLY FOLDED ETANERCEPT COMPOSITION

Patent #:	10435464	Issue Dt:	10/08/2019	Application #:	14845440	Filing Dt:	09/04/2015
Title:	METHODS FOR MAKING RECOMBINANT PROTEINS

Patent #:	9724414	Issue Dt:	08/08/2017	Application #:	14879847	Filing Dt:	10/09/2015
Publication #:	US20160039926	Pub Dt:	02/11/2016
Title:	Stable Aqueous Formulations of Adalimumab

Patent #:	9808525	Issue Dt:	11/07/2017	Application #:	14879885	Filing Dt:	10/09/2015
Publication #:	US20160031982	Pub Dt:	02/04/2016
Title:	Stable Aqueous Formulations of Adalimumab

Patent #:	9943601	Issue Dt:	04/17/2018	Application #:	15078755	Filing Dt:	03/23/2016
Publication #:	US20160199489	Pub Dt:	07/14/2016
Title:	ETANERCEPT FORMULATIONS STABILIZED WITH COMBINATIONS OF SUGARS AND POLYOLS

Patent #:	9682145	Issue Dt:	06/20/2017	Application #:	15155832	Filing Dt:	05/16/2016
Publication #:	US20160256545	Pub Dt:	09/08/2016
Title:	Stable Aqueous Formulations of Adalimumab

Patent #:	9707293	Issue Dt:	07/18/2017	Application #:	15155925	Filing Dt:	05/16/2016
Publication #:	US20160256546	Pub Dt:	09/08/2016
Title:	Stable Aqueous Formulations of Adalimumab

Patent #:	9789185	Issue Dt:	10/17/2017	Application #:	15155982	Filing Dt:	05/16/2016
Publication #:	US20160256547	Pub Dt:	09/08/2016
Title:	Stable Aqueous Formulations of Adalimumab

Patent #:	9757454	Issue Dt:	09/12/2017	Application #:	15162140	Filing Dt:	05/23/2016
Publication #:	US20160263226	Pub Dt:	09/15/2016
Title:	Stable Aqueous Formulations of Adalimumab

Patent #:	9770507	Issue Dt:	09/26/2017	Application #:	15193345	Filing Dt:	06/27/2016
Publication #:	US20160304599	Pub Dt:	10/20/2016
Title:	Stable Aqueous Formulations of Adalimumab

Patent #:	9731008	Issue Dt:	08/15/2017	Application #:	15193387	Filing Dt:	06/27/2016
Publication #:	US20160304600	Pub Dt:	10/20/2016
Title:	STABLE AQUEOUS FORMULATIONS OF ADALIMUMAB

Patent #:	9737600	Issue Dt:	08/22/2017	Application #:	15193415	Filing Dt:	06/27/2016
Publication #:	US20160304601	Pub Dt:	10/20/2016
Title:	Stable Aqueous Formulations of Adalimumab

Patent #:	9782480	Issue Dt:	10/10/2017	Application #:	15193454	Filing Dt:	06/27/2016
Publication #:	US20160303233	Pub Dt:	10/20/2016
Title:	Stable Aqueous Formulations of Adalimumab

Patent #:	9724415	Issue Dt:	08/08/2017	Application #:	15193486	Filing Dt:	06/27/2016
Publication #:	US20160303234	Pub Dt:	10/20/2016
Title:	Stable Aqueous Formulations of Adalimumab

Patent #:	9731009	Issue Dt:	08/15/2017	Application #:	15193523	Filing Dt:	06/27/2016
Publication #:	US20160303235	Pub Dt:	10/20/2016
Title:	Stable Aqueous Formulations of Adalimumab

Patent #:	9770510	Issue Dt:	09/26/2017	Application #:	15209484	Filing Dt:	07/13/2016
Publication #:	US20160317667	Pub Dt:	11/03/2016
Title:	Etanercept Formulations Stabilized with Xylitol

Patent #:	11229702	Issue Dt:	01/25/2022	Application #:	15337519	Filing Dt:	10/28/2016
Title:	HIGH CONCENTRATION FORMULATIONS OF ADALIMUMAB

Patent #:	11583584	Issue Dt:	02/21/2023	Application #:	15337845	Filing Dt:	10/28/2016
Title:	STABLE ADALIMUMAB COMPOSITIONS AND METHODS OF THEIR USE

Patent #:	9861695	Issue Dt:	01/09/2018	Application #:	15360678	Filing Dt:	11/23/2016
Publication #:	US20170072054	Pub Dt:	03/16/2017
Title:	STABLE AQUEOUS FORMULATIONS OF ADALIMUMAB

Patent #:	9867816	Issue Dt:	01/16/2018	Application #:	15402941	Filing Dt:	01/10/2017
Publication #:	US20170143687	Pub Dt:	05/25/2017
Title:	PPAR GAMMA AGONISTS FOR TREATMENT OF MULTIPLE SCLEROSIS

Patent #:	11071782	Issue Dt:	07/27/2021	Application #:	15492999	Filing Dt:	04/20/2017
Publication #:	US20170304445	Pub Dt:	10/26/2017
Title:	METHOD OF FILLING A CONTAINER WITH NO HEADSPACE

Patent #:	10780163	Issue Dt:	09/22/2020	Application #:	15653228	Filing Dt:	07/18/2017
Publication #:	US20170312361	Pub Dt:	11/02/2017
Title:	Stable Aqueous Formulations of Adalimumab

Patent #:	10786566	Issue Dt:	09/29/2020	Application #:	15677857	Filing Dt:	08/15/2017
Publication #:	US20180021433	Pub Dt:	01/25/2018
Title:	STABLE AQUEOUS FORMULATIONS OF ADALIMUMAB

Patent #:	11001627	Issue Dt:	05/11/2021	Application #:	15720291	Filing Dt:	09/29/2017
Publication #:	US20180037642	Pub Dt:	02/08/2018
Title:	CORRECTLY FOLDED ETANERCEPT IN HIGH PURITY AND EXCELLENT YIELD

Patent #:	10159732	Issue Dt:	12/25/2018	Application #:	15726165	Filing Dt:	10/05/2017
Publication #:	US20180043018	Pub Dt:	02/15/2018
Title:	Stable Aqueous Formulations of Adalimumab

Patent #:	10207000	Issue Dt:	02/19/2019	Application #:	15726195	Filing Dt:	10/05/2017
Publication #:	US20180055929	Pub Dt:	03/01/2018
Title:	Stable Aqueous Formulations of Adalimumab

Patent #:	10159733	Issue Dt:	12/25/2018	Application #:	15726215	Filing Dt:	10/05/2017
Publication #:	US20180043019	Pub Dt:	02/15/2018
Title:	Stable Aqueous Formulations of Adalimumab

Patent #:	10286071	Issue Dt:	05/14/2019	Application #:	15729243	Filing Dt:	10/10/2017
Publication #:	US20180028653	Pub Dt:	02/01/2018
Title:	Syringe Containing Stable Aqueous Formulations of Adalimumab

Patent #:	10286072	Issue Dt:	05/14/2019	Application #:	15729295	Filing Dt:	10/10/2017
Title:	METHODS OF MANUFACTURING STABLE AQUEOUS FORMULATIONS OF ADALIMUMAB

Patent #:	11135267	Issue Dt:	10/05/2021	Application #:	15799798	Filing Dt:	10/31/2017
Publication #:	US20180125982	Pub Dt:	05/10/2018
Title:	Etanercept Formulations Stabilized with Metal Ions

Patent #:	10155039	Issue Dt:	12/18/2018	Application #:	15799851	Filing Dt:	10/31/2017
Publication #:	US20180055930	Pub Dt:	03/01/2018
Title:	Stable Aqueous Formulations of Adalimumab

Patent #:	10195275	Issue Dt:	02/05/2019	Application #:	15866154	Filing Dt:	01/09/2018
Publication #:	US20180140701	Pub Dt:	05/24/2018
Title:	STABLE AQUEOUS FORMULATIONS OF ADALIMUMAB

Patent #:	10793637	Issue Dt:	10/06/2020	Application #:	15931469	Filing Dt:	05/13/2020
Publication #:	US20200277394	Pub Dt:	09/03/2020
Title:	Antibodies That Bind CD39 and Uses Thereof

Patent #:	11312783	Issue Dt:	04/26/2022	Application #:	16014744	Filing Dt:	06/21/2018
Publication #:	US20190031766	Pub Dt:	01/31/2019
Title:	ANTIBODY MOLECULES TO CD73 AND USES THEREOF

Patent #:	10772959	Issue Dt:	09/15/2020	Application #:	16023046	Filing Dt:	06/29/2018
Publication #:	US20180311349	Pub Dt:	11/01/2018
Title:	STABLE AQUEOUS FORMULATIONS OF ADALIMUMAB

Patent #:	10772960	Issue Dt:	09/15/2020	Application #:	16023152	Filing Dt:	06/29/2018
Publication #:	US20180311350	Pub Dt:	11/01/2018
Title:	STABLE AQUEOUS FORMULATIONS OF ADALIMUMAB

Patent #:	10799585	Issue Dt:	10/13/2020	Application #:	16023161	Filing Dt:	06/29/2018
Publication #:	US20180311351	Pub Dt:	11/01/2018
Title:	STABLE AQUEOUS FORMULATIONS OF ADALIMUMAB

Patent #:	10688183	Issue Dt:	06/23/2020	Application #:	16023205	Filing Dt:	06/29/2018
Publication #:	US20180311352	Pub Dt:	11/01/2018
Title:	STABLE AQUEOUS FORMULATIONS OF ADALIMUMAB

Patent #:	11001623	Issue Dt:	05/11/2021	Application #:	16102157	Filing Dt:	08/13/2018
Publication #:	US20180346550	Pub Dt:	12/06/2018
Title:	METHOD OF MANUFACTURING A PROTEIN BY PERFUSION IN MEDIA WITH A LOW AMINO ACID CONCENTRATION

Patent #:	10722579	Issue Dt:	07/28/2020	Application #:	16178137	Filing Dt:	11/01/2018
Publication #:	US20190060455	Pub Dt:	02/28/2019
Title:	STABLE AQUEOUS FORMULATIONS OF ADALIMUMAB

Patent #:	10716852	Issue Dt:	07/21/2020	Application #:	16178164	Filing Dt:	11/01/2018
Publication #:	US20190070292	Pub Dt:	03/07/2019
Title:	STABLE AQUEOUS FORMULATIONS OF ADALIMUMAB

Patent #:	10716853	Issue Dt:	07/21/2020	Application #:	16178309	Filing Dt:	11/01/2018
Publication #:	US20190070293	Pub Dt:	03/07/2019
Title:	STABLE AQUEOUS FORMULATIONS OF ADALIMUMAB

Patent #:	10716854	Issue Dt:	07/21/2020	Application #:	16178319	Filing Dt:	11/01/2018
Publication #:	US20190070294	Pub Dt:	03/07/2019
Title:	STABLE AQUEOUS FORMULATIONS OF ADALIMUMAB

Patent #:	10772963	Issue Dt:	09/15/2020	Application #:	16284265	Filing Dt:	02/25/2019
Publication #:	US20190184017	Pub Dt:	06/20/2019
Title:	ETANERCEPT FORMULATIONS STABILIZED WITH XYLITOL

Patent #:	11667702	Issue Dt:	06/06/2023	Application #:	16297387	Filing Dt:	03/08/2019
Publication #:	US20190276528	Pub Dt:	09/12/2019
Title:	Stable Aqueous Formulations of Aflibercept

Patent #:	10738128	Issue Dt:	08/11/2020	Application #:	16352589	Filing Dt:	03/13/2019
Publication #:	US20190284295	Pub Dt:	09/19/2019
Title:	Antibodies That Bind CD39 and Uses Thereof

Patent #:	11129876	Issue Dt:	09/28/2021	Application #:	16360196	Filing Dt:	03/21/2019
Publication #:	US20190216930	Pub Dt:	07/18/2019
Title:	ETANERCEPT FORMULATIONS STABILIZED WITH AMINO ACIDS

Patent #:	11332524	Issue Dt:	05/17/2022	Application #:	16362457	Filing Dt:	03/22/2019
Publication #:	US20190382474	Pub Dt:	12/19/2019
Title:	ANTI-IL-27 ANTIBODIES AND USES THEREOF

Patent #:	10980884	Issue Dt:	04/20/2021	Application #:	16441092	Filing Dt:	06/14/2019
Publication #:	US20190290766	Pub Dt:	09/26/2019
Title:	Stable Aqueous Etanercept Composition

Patent #:	10980885	Issue Dt:	04/20/2021	Application #:	16441095	Filing Dt:	06/14/2019
Publication #:	US20190290767	Pub Dt:	09/26/2019
Title:	Method of Reducing Formation of Etanercept Aggregates or Fragments

Patent #:	10888619	Issue Dt:	01/12/2021	Application #:	16441103	Filing Dt:	06/14/2019
Publication #:	US20190290768	Pub Dt:	09/26/2019
Title:	Stable Aqueous Etanercept Composition

Patent #:	10987405	Issue Dt:	04/27/2021	Application #:	16441110	Filing Dt:	06/14/2019
Publication #:	US20190298837	Pub Dt:	10/03/2019
Title:	Method of Reducing Formation of Etanercept Aggregates or Fragments

Patent #:	10954293	Issue Dt:	03/23/2021	Application #:	16443514	Filing Dt:	06/17/2019
Publication #:	US20190300600	Pub Dt:	10/03/2019
Title:	CORRECTLY FOLDED ETANERCEPT IN HIGH PURITY AND EXCELLENT YIELD

Patent #:	10954294	Issue Dt:	03/23/2021	Application #:	16443594	Filing Dt:	06/17/2019
Publication #:	US20190300601	Pub Dt:	10/03/2019
Title:	CORRECTLY FOLDED ETANERCEPT IN HIGH PURITY AND EXCELLENT YIELD

Patent #:	10947306	Issue Dt:	03/16/2021	Application #:	16443688	Filing Dt:	06/17/2019
Publication #:	US20190330325	Pub Dt:	10/31/2019
Title:	CORRECTLY FOLDED ETANERCEPT IN HIGH PURITY AND EXCELLENT YIELD

Patent #:	10954295	Issue Dt:	03/23/2021	Application #:	16443721	Filing Dt:	06/17/2019
Publication #:	US20190300602	Pub Dt:	10/03/2019
Title:	CORRECTLY FOLDED ETANERCEPT IN HIGH PURITY AND EXCELLENT YIELD

Patent #:	11000588	Issue Dt:	05/11/2021	Application #:	16456267	Filing Dt:	06/28/2019
Publication #:	US20190343955	Pub Dt:	11/14/2019
Title:	Etanercept Formulations Stabilized with Sodium Chloride

Patent #:	11253508	Issue Dt:	02/22/2022	Application #:	16497523	Filing Dt:	09/25/2019
Publication #:	US20210283121	Pub Dt:	09/16/2021
Title:	PPARy AGONIST FOR TREATMENT OF PROGRESSIVE SUPRANUCLEAR PALSY

Patent #:	11279758	Issue Dt:	03/22/2022	Application #:	16516613	Filing Dt:	07/19/2019
Publication #:	US20200040081	Pub Dt:	02/06/2020
Title:	Anti-CD112R Compositions and Methods

Patent #:	11396540	Issue Dt:	07/26/2022	Application #:	16564642	Filing Dt:	09/09/2019
Title:	METHODS FOR MAKING RECOMBINANT PROTEINS

Patent #:	11426446	Issue Dt:	08/30/2022	Application #:	16566847	Filing Dt:	09/10/2019
Publication #:	US20200246423	Pub Dt:	08/06/2020
Title:	STABLE AQUEOUS FORMULATIONS OF AFLIBERCEPT

Patent #:	10772865	Issue Dt:	09/15/2020	Application #:	16744433	Filing Dt:	01/16/2020
Publication #:	US20200147036	Pub Dt:	05/14/2020
Title:	METHODS FOR THE TREATMENT OF NONALCOHOLIC FATTY LIVER DISEASE AND/OR LIPODYSTROPHY

Patent #:	11400072	Issue Dt:	08/02/2022	Application #:	16911721	Filing Dt:	06/25/2020
Publication #:	US20200383945	Pub Dt:	12/10/2020
Title:	METHODS FOR THE TREATMENT OF NONALCOHOLIC FATTY LIVER DISEASE AND/OR LIPODYSTROPHY

Patent #:	11655303	Issue Dt:	05/23/2023	Application #:	17021223	Filing Dt:	09/15/2020
Publication #:	US20210095041	Pub Dt:	04/01/2021
Title:	Anti-CD39 Antibody Compositions and Methods

Patent #:	NONE	Issue Dt:		Application #:	17059056	Filing Dt:	11/25/2020
Publication #:	US20210214459	Pub Dt:	07/15/2021
Title:	ANTIBODY MOLECULES TO CD73 AND USES THEREOF

Patent #:	11214619	Issue Dt:	01/04/2022	Application #:	17261463	Filing Dt:	01/19/2021
Publication #:	US20210253699	Pub Dt:	08/19/2021
Title:	Anti-CD112R Compositions and Methods

Patent #:	11576971	Issue Dt:	02/14/2023	Application #:	17350299	Filing Dt:	06/17/2021
Publication #:	US20220040300	Pub Dt:	02/10/2022
Title:	METHOD OF FILLING A CONTAINER WITH NO HEADSPACE

Patent #:	NONE	Issue Dt:		Application #:	17413269	Filing Dt:	06/11/2021
Publication #:	US20220259299	Pub Dt:	08/18/2022
Title:	ANTI-IL-27 ANTIBODIES AND USES THEREOF

Patent #:	NONE	Issue Dt:		Application #:	17419559	Filing Dt:	06/29/2021
Publication #:	US20220143003	Pub Dt:	05/12/2022
Title:	COMPOSITIONS AND METHODS TO TREAT NON-ALCOHOLIC FATTY LIVER DISEASES (NAFLD)

Patent #:	NONE	Issue Dt:		Application #:	17531380	Filing Dt:	11/19/2021
Publication #:	US20220162317	Pub Dt:	05/26/2022
Title:	Anti-CD112R Compositions and Methods

Patent #:	NONE	Issue Dt:		Application #:	17600168	Filing Dt:	09/30/2021
Publication #:	US20220193102	Pub Dt:	06/23/2022
Title:	COMPOSITIONS AND METHODS TO TREAT NON-ALCOHOLIC FATTY LIVER DISEASES (NAFLD)

Patent #:	NONE	Issue Dt:		Application #:	17600172	Filing Dt:	09/30/2021
Publication #:	US20220193065	Pub Dt:	06/23/2022
Title:	COMPOSITIONS AND METHODS TO TREAT NON-ALCOHOLIC FATTY LIVER DISEASES (NAFLD)

Patent #:	NONE	Issue Dt:		Application #:	17600178	Filing Dt:	09/30/2021
Publication #:	US20220288053	Pub Dt:	09/15/2022
Title:	COMPOSITIONS AND METHODS TO TREAT NON-ALCOHOLIC FATTY LIVER DISEASES (NAFLD)

Patent #:	NONE	Issue Dt:		Application #:	17600182	Filing Dt:	09/30/2021
Publication #:	US20220288054	Pub Dt:	09/15/2022
Title:	COMPOSITIONS AND METHODS TO TREAT NON-ALCOHOLIC FATTY LIVER DISEASES (NAFLD)

Patent #:	NONE	Issue Dt:		Application #:	17600194	Filing Dt:	09/30/2021
Publication #:	US20220175758	Pub Dt:	06/09/2022
Title:	COMPOSITIONS AND METHODS TO TREAT NON-ALCOHOLIC FATTY LIVER DISEASES (NAFLD)

Patent #:	NONE	Issue Dt:		Application #:	17613012	Filing Dt:	11/19/2021
Publication #:	US20220202804	Pub Dt:	06/30/2022
Title:	COMPOSITIONS AND METHODS TO TREAT CANCER

Patent #:	NONE	Issue Dt:		Application #:	17695267	Filing Dt:	03/15/2022
Publication #:	US20230039109	Pub Dt:	02/09/2023
Title:	ANTIBODY MOLECULES TO CD73 AND USES THEREOF

Patent #:	NONE	Issue Dt:		Application #:	17714942	Filing Dt:	04/06/2022
Publication #:	US20230042258	Pub Dt:	02/09/2023
Title:	ANTI-IL-27 ANTIBODIES AND USES THEREOF

Patent #:	NONE	Issue Dt:		Application #:	17738927	Filing Dt:	05/06/2022
Publication #:	US20220389089	Pub Dt:	12/08/2022
Title:	ANTI-IL-27 ANTIBODIES AND USES THEREOF

Patent #:	NONE	Issue Dt:		Application #:	17765294	Filing Dt:	03/30/2022
Publication #:	US20220339360	Pub Dt:	10/27/2022
Title:	CONTROL MECHANISM FOR PRIMING AN INJECTION DEVICE

Patent #:	NONE	Issue Dt:		Application #:	17768538	Filing Dt:	04/13/2022
Publication #:	US20240066020	Pub Dt:	02/29/2024
Title:	COMPOSITIONS AND METHODS TO TREAT NON-ALCOHOLIC FATTY LIVER DISEASES (NAFLD)

Patent #:	NONE	Issue Dt:		Application #:	17830817	Filing Dt:	06/02/2022
Publication #:	US20230036592	Pub Dt:	02/02/2023
Title:	METHODS OF TREATING CANCER WITH AN ANTI-CD39 ANTIBODY AND PEMBROLIZUMAB

Patent #:	NONE	Issue Dt:		Application #:	18201620	Filing Dt:	05/24/2023
Publication #:	US20240026001	Pub Dt:	01/25/2024
Title:	USE OF ANTI-IL-27 ANTIBODIES

Patent #:	NONE	Issue Dt:		Application #:	18201626	Filing Dt:	05/24/2023
Publication #:	US20240025987	Pub Dt:	01/25/2024
Title:	USE OF ANTI-IL-27 ANTIBODIES

Assignors

COHERUS BIOSCIENCES, INC.

Exec Dt:

05/08/2024

COHERUS INTERMEDIATE CORP.

Exec Dt:

05/08/2024

INTEKRIN THERAPEUTICS INC.

Exec Dt:

05/08/2024

SURFACE ONCOLOGY, LLC

Exec Dt:

05/08/2024

COHERUS ONCOLOGY SUPPORTIVE CARE LLC

Exec Dt:

05/08/2024

Assignee

ANKURA TRUST COMPANY, LLC

140 SHERMAN STREET, 4TH FLOOR

FAIRFIELD, CONNECTICUT 06824

Correspondence name and address
	MOIRA SHEEHAN
	650 SOUTH TRYON STREET
	SUITE 1400
	CHARLOTTE, NC 28202

Search Results as of: 06/25/2024 12:02 AM

If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6

Web interface last modified: August 25, 2017 v.2.6